Article

Cataract surgery cost-effective

Contrary to claims made in a recent op-ed piece in the Wall Street Journal, cataract surgery ?is one of the most cost-effective major surgical procedures available today,? said American Academy of Ophthalmology (AAO) President Richard L. Abbott, MD, in an open letter.

San Francisco-Contrary to claims made in a recent op-ed piece in The Wall Street Journal, cataract surgery “is one of the most cost-effective major surgical procedures available today,” said American Academy of Ophthalmology (AAO) President Richard L. Abbott, MD, in an open letter.

In “Three simple ways Medicare can save money,” published Aug. 11, National Center for Policy Analysis President and Chief Executive Officer John C. Goodman used inaccurate data when describing ways to improve the Medicare program, Dr. Abbott said.

As an example of a flawed Medicare system, Goodman said: “This year, Medicare is paying $111.36 for the [primary-care physician (PCP)] visit. The ophthalmologist, meanwhile, is raking in $836.36 (including the patient co-payment). Medicare is paying 7.5 times more for cataract removal than for a primary care visit. If we measure according to the time spent to earn the fee, Medicare is paying the ophthalmologist 15 times what it pays the PCP.”

The calculation, according to Dr. Abbott, fails to consider that the true time needed to perform cataract surgery is 30 minutes, not the 10 to 15 minutes Goodman cited. Further, according to Dr. Abbott, the calculation does not factor in the 3 months of follow-up exams required after the surgery and the 10% payment bonus paid to PCPs in 2011.

Ophthalmologists effectively receive $221 from Medicare for cataract surgery after accounting for practice expenses, malpractice costs, and $222 for postoperative office visits, Dr. Abbott contended. In contrast, he said, a PCP receives $51 (“pre-bonus”) for an office visit.

“One can debate whether this 4:1 ratio is proper, but it is not the 15:1 ratio that Mr. Goodman dramatically claims,” Dr. Abbott wrote. “Nor do we feel that most patients would consider $221 to be an exorbitant charge for a technically challenging and ever-changing operation with remarkably high success in safely restoring vision and functional ability.”

Just as the services provided by ophthalmologists hold much value, PCPs play a “vital role” in health care, Dr. Abbott wrote. “We will continue to work with them, as we have in the past, to develop physician compensation models that reflect a patient-centered, value-based approach for physician payment.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.